• In vivo function of platelets stored at various conditions was studied in normo-and hypotension.
Essentials
• In vivo function of platelets stored at various conditions was studied in normo-and hypotension.
• Refrigerated platelets stored up to 5 days performed as well as those stored at room temperature.
• Platelet adhesion and thrombus formation were higher in ruptured vessels of hemorrhaged animals.
• In vivo data suggest that refrigerated platelets are hemostatically effective during hypotension.
Summary. Background:
There is renewed interest in the therapeutic use of cold-stored platelets for bleeding patients. However, critical information is absent or partially available in vitro. Therefore, thrombus formation and platelet adhesion were studied in vivo, in situ, using bleeding and thrombosis models in instrumented rats, and confocal intravital videomicroscopy. Objectives We tested the hypothesis that refrigerated (4°C) platelets (stored for 24 h or 5 days) participated in thrombus formation as well as platelets stored at room temperature (RT, 22°C). This hypothesis was tested in normovolemia and hemorrhagic hypotension. Methods & Results: After fluorescently-labeled platelet infusion, endothelial injury and vessel rupture were laser-induced in cremaster microvessels and platelet adhesion in > 230 developing thrombi was evaluated. Blood samples were collected for biochemistry and coagulation assays while multiple systemic physiologic parameters were recorded. Hemorrhagic hypotension study animals were subjected to 40% hemorrhage, leading to hypotension and hemodilution, during in vivo platelet adhesion assessments. The fluorescence intensity associated with labeled platelet adherence provided a quantitative index of adhesion. Cold-stored platelets performed as well as those stored at RT in normovolemic animals. During hypotension, cold-stored platelets still performed as well as RT-stored platelets, whereas platelet adhesion and thrombus formation were increased relative to normovolemic animals, in bleeding model experiments. Conclusions: We found the methodology suitable for evaluating platelet function in vivo after different storage conditions in fully monitored animals.
Introduction
Damage control resuscitation principles support a balanced ratio of plasma to red blood cells to platelets; as a component of this therapeutic strategy, platelets have been administered to patients with severe traumatic bleeding [1] [2] [3] [4] . Assessments of hemostatic responses following hemorrhagic shock (HS) and trauma have shown platelet dysfunction despite normal count at admission [5] [6] [7] [8] . Therefore, HS is an important context for platelet usage, and further understanding of platelet function under these conditions is required. In vitro data suggest that refrigerated (4°C) platelets, whether as concentrates or in refrigerated whole blood (WB), may be superior to platelets stored at room temperature (RT, 22°C) for controlling hemorrhage [9] . These expectations were confirmed by randomized controlled clinical trials that evaluated refrigerated platelets as concentrates and as an element of cold-stored WB [10, 11] . However, because of limitations in those studies, the clinical value of platelets stored for more than 72 h in the cold remains in the realm of extrapolation from in vitro data. Storage at RT may not provide platelets with the hemostatic effectiveness of platelets stored at 4°C for treatment of bleeding patients and cold-stored platelets have been suggested as a more widely available therapeutic option [12] . All in all, no data have yet been obtained in vivo, under physiologic blood flow and hypovolemia, on the effects of platelet storage conditions such as temperature and prolonged storage time. During thrombus formation, platelets interact with endothelial cells, with each other, and with intravascular molecules, cells and particles [13] . Although all these complex interactions occur under pressurized flowing blood [14] and cannot be reproduced in vitro, thrombus formation and platelet function tests currently rely almost exclusively on in vitro assays [15] . However, hemodynamic and hemostatic responses should be studied in concert and in vivo [16] , especially after challenges such as HS.
The laser-induced thrombus technique combines reproducibility, accuracy and sensitivity for quantification of thrombus growth and platelet adhesion in vivo [17] . Nearly all studies utilize mice as experimental subjects but systemic physiologic parameters such as arterial blood pressure are typically neither monitored nor altered [13, 17, 18] .
Considering the advantages of allowing hemorrhagic hypotension (HH) and multiple blood sampling, we developed a new model to evaluate in vivo thrombus formation, platelet adhesion and relevant systemic parameters using fully instrumented rats. We tested the hypothesis that refrigerated platelets (stored for 24 h or 5 days) participated in laser-induced thrombus formation as well as RT-stored platelets in normovolemic and hemorrhaged animals. To further test the adequacy of refrigerated platelets for treatment of bleeding during HS, we used a bleeding model in which platelet adhesion during thrombus formation was evaluated in vivo after vessels were ruptured using a laser.
Methods
This study was conducted in compliance with the Animal Welfare Act, implementing Animal Welfare Regulations, and the principles of the Guide for the Care and Use of Laboratory Animals, using protocols approved by the Institutional Animal Care and Use Committee of the US Army ISR. Fifty male Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA, USA, 229 AE 9 g body mass) breathing spontaneously 100% oxygen were anesthetized (isoflurane, 2%) and tracheostomized.
Systemic measurements
One carotid artery was cannulated for monitoring blood pressure, one femoral vein was used to infuse fluorescent platelets and other fluids, and one femoral artery was used for blood withdrawal and sampling. Blood was collected into heparinized capillary tubes for hematocrit measurement (microhematocrit centrifuge model MB, Damon/ IEC, Needham Heights, MA, USA). Platelet count and mean platelet volume (MPV) were determined in duplicate using a cell counter (Coulter Ac-T diff2 Hematology System; Beckman Coulter, Brea, CA, USA). Blood hemoglobin concentration, pH, K + (mM), PCO 2 (mmHg), PO 2 (mmHg), bicarbonate (mM) and lactate (mM) were measured (i-STAT, Abbott, Chicago, IL, USA). Hemostasis was tested in vitro using rotational thromboelastometry (ROTEM, TEM Systems, Inc., Durham, NC, USA) by measuring clotting time (CT, s), maximum clot firmness (MCF, mm), a-angle (degrees), clot strength (G, dynes cm
À2
) and platelet component. Hemoglobin O 2 saturation (SO 2 ) and respiratory rate (RR) were measured non-invasively (MouseOx, Starr Lifesciences, Oakmont, PA, USA). Arterial blood pressure, heart rate, core temperature, SO 2 and RR were monitored and continuously recorded using a computerized acquisition system (MP150, Biopac, Goleta, CA, USA) that also calculated the mean arterial blood pressure (MAP).
Intravital microscopy
We implemented a system for confocal intravital videomicroscopy of the microcirculation (Fig. 1) . The microscope (Examiner, model Z1, Zeiss, Thornwood, NY, USA) included a confocal head, laser, motorized stage (Applied Scientific Instrumentation, Eugene, OR, USA) and waterimmersion objective (63x, 1.00-NA, Plan-Apochromat, Zeiss) mounted on the motorized microscope head. Cremaster areas (170 9 130 lm) were recorded and saved in tagged image format (TIF). The effective magnification yielded a pixel spacing of 11.45 pixels lm À1 . In most experiments, the images were switched to a second camera (model DXC-C33, Sony, New York, NY, USA) attached to an optical velocimeter for red blood cell (RBC) velocity measurements. Microvascular blood flow and wall shear rate (WSR) were determined using the mean RBC velocity and vessel diameter [19] .
Experimental animal preparation
The cremaster muscle was exteriorized and positioned flat over a thermostatically-controlled pedestal [20] . During surgery, the muscle was continuously bathed by a warm KrebsHenseleit solution. After exposure, the preparation was covered with an impermeable plastic film. The animal platform was then positioned over the microscope stage.
Whole blood and fluorescently-labeled platelet preparation
Blood from anesthetized donor rats, mixed with citratephosphate-dextrose (CPD, 9 : 1 ratio), stored at 4°C or 22°C, was used within 24 h (Group 1). Blood from donor Group 2 was sterilely transferred into 15-mL BCSI mini-bags (Seattle, WA, USA) and stored for 5 days in a walk-in refrigerator at 4°C without agitation [9] . Platelets were separated from drawn blood by centrifugation, pelleted and resuspended in modified Tyrode's albumin buffer (MTAB, 137 mM NaCl, 2.7 mM KCl, 12 mM NaHCO 3 , 5 nM HEPES, 0.43 mM NaH 2 PO 4 , 1.0 mM glucose, 1.0 mM MgCl 2 , containing 0.35% BSA) with 0.02 U mL À1 apyrase and 1.0 lM PGI 2 . Washed platelets were resuspended in MTAB, incubated with 20 lM carboxyfluorescein diacetate (Vybrant Cell Tracer Kit, Invitrogen) for 1 h in the dark at RT, centrifuged, and resuspended in 500 lL MTAB before injection into a recipient rat. We infused %500-600 9 10 8 platelets (%10% of the total endogenous platelet number as shown by FACS analysis) into each rat.
Aggregometry Aggregation was tested in vitro by light transmittance with a Lumi-Aggregometer (model 700, Chrono-Log Corporation, Chicago, IL, USA) using 2 9 10 5 platelets from platelet-rich plasma. Immediately before the agonist, 2 mM CaCl 2 was added to compensate for the citrate effect on the calcium. Aggregation was induced by adenosine diphosphate (5 lM) during stirring and recorded. The results were expressed as per cent amplitude at 12 min after the challenge and as area under the curve (AUC).
Flow cytometry Resting platelets (1 9 10 6 cells) or citrated WB in PBS were incubated with PE-labeled CD62P, clone KO2.3 (catalog # 12-0626-82, eBioscience, San Diego, CA, USA). Samples were then diluted with PBS and analyzed on a BD FACSCanto flow cytometer equipped with 488 and 633 nm lasers. Platelets were identified by forward and side-scatter characteristics. The CD62P positivity was determined using appropriate isotype controls.
Animal groups and hemorrhage model
Normotensive (NOR) and hemorrhaged (HEM) animals were used. In HEM animals, a fixed-volume hemorrhage protocol produced a realistic HS model where the MAP produced endothelial damage in cremaster microvessels. Previously injected fluorescently-labeled platelets stored at room temperature or at 4°C were imaged and recorded using a confocal scanner spinning disc head (CSUX1-M1N-E, Yokogawa, Japan), laser (Coherent, Inc., Santa Clara, CA, USA) and camera (Orca Flash 4.0, Hamamatsu, Bridgewater, NJ, USA). Halogen illumination was used for the bright-field. Red blood cell velocity was measured on-line (Optical Doppler Velocimeter, Texas A&M, College Station, TX, USA). The hemorrhage was induced using synchronized syringe pumps 1 and 2. Systemic parameters of the rat were simultaneously recorded while blood samples were collected for immediate analysis (ROTEM, FACS, biochemistry, etc.) SO 2 , oxygen saturation; RR, respiratory rate; SP, DP, MAP, systolic, diastolic and mean arterial blood pressure; HR, heart rate. [Color figure can be viewed at wileyonlinelibrary.com]
was not kept at any predetermined level [21] . The hemorrhage was induced in 30 min (Figs 1, 2) , to a target of 40% of the estimated total blood volume (6% of body mass). HEM animals were left under HS for 2 h. Normovolemic animals were subjected to all procedures except hemorrhage. Each animal group was further subdivided into groups receiving fluorescently-labeled platelets stored at 4°C (24 h or 5 days) or 22°C (24 h). Because the labeled-platelets injection procedure was the same regardless of the storage process used, the type of platelet injected is not always specifically mentioned throughout the text.
Experimental protocol
Once the animal was on the microscope, initial tests were conducted by inducing thrombus formation in a few randomly selected venules. Blood samples were then collected for measurement of baseline levels of complete blood count, blood biochemistry and coagulation (ROTEM). A set of systemic parameters was collected, coinciding with biochemistry data. After baseline, as well as hypotensive (HEM group) and normotensive (NOR group) periods, fluorescently-labeled platelets previously stored at 4°C or 22°C were injected, followed by laser-induced thrombus formation. Blood samples and a set of systemic parameters were collected 10 min and 1 h after the injection of fluorescently-labeled platelets. At the end of the protocol, all animals received an injection of euthanasia solution (Fatal-Plus, Vortech Pharmaceuticals Ltd, Dearborn, MI, USA) while under anesthesia. (Fig. 2) Laser-induced microvascular thrombosis model
Thrombus formation was induced using a laser ( Fig. 1) focused through the microscope objective, parfocal with the focal plane and aimed at the inner vessel wall of venules (diameter: 17-40 lm), and a computerized system, similar to that previously described [17, 22] . The severity was comparable to previous laser thrombosis models [17, 18, 22, 23] . Approximately 15 min after the labeled-platelets injection, 5-10 independent experiments were performed over the next 1-2 h (Fig. 2 ).
Laser-induced microvascular bleeding model
Localized microvascular rupture leading to extravasation of plasma and blood cells was induced by increasing the energy of the same thrombosis model laser as described above. The severity was lower than similar laser-based models [24] . Each test produced one rupture, one thrombus per vessel, in vessels from different networks.
Analysis of thrombus formation and stored-platelet adhesion in vivo
Off-line image analysis from recorded TIF sequences (ImageJ, v1.48, NIH, Bethesda, MD, USA) followed a methodology similar to that described previously [18, 22] . Using bright-field images, the area and height of each thrombus were measured. In each vessel, the fluorescence intensity was measured in areas located upstream of the injury site and covering the thrombus (Fig. 4) . This fluorescence came primarily from previously-injected fluorescently-labeled RT-stored or 4C-stored platelets flowing, adhering to the thrombus (formed mostly by unlabeled native platelets) or moving/adhering anywhere within the areas being analyzed. The mean integrated fluorescence intensity difference associated with the adherence of labeled stored-platelets to the thrombus provided a quantitative index of in vivo adhesion. Data from multiple thrombi were used to determine the mean value of storedplatelet adhesion.
Data analysis and statistics
Deviation from Gaussian distribution was tested (ShapiroWilk test) and parametric tests were found adequate on most cases. Values are reported as mean AE SEM (standard error of mean). Differences among more than two groups were analyzed using one-way analysis of variance followed by the Student-Newman-Keuls test. Differences between two groups were tested using Student's t-test or the MannWhitney test when the normality test failed. Power analysis showed that at the standard deviations obtained, a power of 0.8 was reached (alpha = 0.05) using the group sizes tested. We used commercial statistical software (SigmaPlot 12.0, Systat Software, San Jose, CA, USA; Excel 2010, Microsoft Corp, Redmond, WA, USA). P values correspond to two-tailed tests set at 0.05 significance.
Results

Systemic responses
Sixteen animals subjected to all procedures except hemorrhage showed relatively stable systemic parameters throughout the experimental period. The MAP, lactate and potassium levels did not show statistically significant
À1
, respectively. Hemorrhaged animals (N = 34) were bled an average of 24.4 AE 0.4 mL kg À1 (5.4 AE 0.3 mL) and received platelets stored at 4°C or 22°C. The systemic biochemical and hemodynamic responses to hemorrhage in this model have been described in detail by us [20, 25, 26] . Pooled data from sample animals of both groups confirmed that hemorrhage reduced MAP (100.0 AE 1.5 mmHg to 49.5 AE 3.1 mmHg, Fig. 3A ) and increased the shock index (3.1 AE 0.2 to 4.2 AE 0.3). The MAP remained below baseline for the remainder of the experiment, and all animals continued to be hypotensive during platelet adhesion studies (Fig. 3B) . Hemodilution was observed in all groups, leading to a significantly lower hematocrit (compared with baseline) that persisted for 3 h after the hemorrhage began (Fig. 3C ). The RR was not different among animal groups during baseline (71 AE 9 min
) and remained similar after hemorrhage (79 AE 8 min À1 ). Because animals were breathing 100% O 2 , arterial PO 2 and SO 2 remained above 300 mmHg and 99%, respectively, throughout the experiment. No statistically significant changes occurred in systemic parameters before and after injection of platelets (data not shown).
In vitro tests
Coagulation (ROTEM) tests at baseline, post-hemorrhage (t = 30 min) and 1 h after platelet injection (Table 1) showed that the stored-platelets injection did not seem to affect hemostasis in NOR animals, except for CT (significantly lower than baseline, P < 0.05). In the HEM group, CT significantly decreased after hemorrhage (P < 0.05). However, after stored-platelets injection, hemorrhaged rats showed recovery in CT to baseline levels, and significantly better coagulation response compared with after the hemorrhage (higher clot firmness and strength, P < 0.05).
In vitro tests performed in the blood and platelets used for injections (Fig. 4) 
In vivo tests
In normotensive and hypotensive animals, fluorescence and bright-field images from thrombi were captured while systemic parameters were monitored. The stored-platelet recruitment efficacy into a thrombus was studied by infusing platelets stored at various temperatures (4°C, 22°C) and durations (< 24 h, 5 days). Thrombus formation was initiated in different microvessels using two laser-based approaches: without microvascular rupture (thrombosis model) and with microvascular wall rupture (bleeding model). Approximately 40% of microvessels were ruptured. A typical thrombus (Fig. 5G) included unlabeled native platelets, fluorescently-labeled platelets, and occasionally leukocytes and RBCs. These labeled-platelets (RT-stored and cold-stored) did not adhere to or form thrombi in uninjured vessels (Fig. 5D ). Quantitative in vivo evaluation of the adhesion of fluorescently-labeled platelets was performed for each thrombus (Fig. 5A-C ).
Thrombus size: thrombosis model. Thrombi produced in animals receiving cold-stored and RT-stored platelets had similar sizes in the NOR (Fig. 6A) and HEM (Fig. 6C ) groups. Thrombi sizes were similar in animals that received infusion of refrigerated platelets stored for 5 days (Fig. 6E) .
Thrombus size: bleeding model. Thrombi produced in animals that received cold-stored and RT-stored platelets also had similar sizes in the NOR (Fig. 6B) and HEM (Fig. 6D) groups. In animals that received platelets stored for 5 days, the thrombi were larger during HH (Fig. 6F) .
Stored platelet adhesion in vivo: thrombosis model. Platelets stored at both temperatures adhered equally well to thrombi in normotensive (Fig. 7A) and hemorrhaged (Fig. 7C) animals. Adhesion was lower in HEM than in NOR animals (Fig. 7E) . Refrigerated platelets stored for 5 days adhered equally well to thrombi produced in HEM and NOR animals (Fig. 7G) . Stored platelet adhesion in vivo: bleeding model. Platelets stored at both temperatures adhered equally well to thrombi in normotensive (Fig. 7B) and hemorrhaged (Fig. 7D) animals. Adherence during HH was significantly higher than that measured in NOR animals (Fig. 7F) . Adhesion of 5-day refrigerated platelets was also higher in HEM animals than in NOR animals (Fig. 7H) .
In NOR animals, microvascular diameter, blood flow and WSR averages were 15.7 AE 0.6 lm, 0.9 AE 0.1 nL s
À1
and 705 AE 101 s À1 , respectively. For both temperatures of the HEM group, the adherence was the same regardless of the fraction of fluorescently-labeled platelets in the animal. Microvascular diameter, blood flow and WSR averaged 16.8 AE 0.6 lm, 0.7 AE 0.1 nL s À1 and 500 AE 100 s
, respectively, for HEM animals. These values were not significantly different from baseline.
The clearance of fluorescently-labeled platelets was measured by the fraction of labeled platelets 10 min and 1 h after injection. The average difference was 1% (10% at 10 min, 9% at 70 min). The difference was statistically the same between the NOR and HEM groups, and between animals that received RT-stored and cold-stored platelets.
Discussion
This study provides new in vivo data on the ability of refrigerated platelets stored up to 5 days to participate in thrombus formation during normovolemia and hypotension. Despite its critical importance, platelet adhesion during thrombus formation has been poorly studied under physiologic blood flow. Our knowledge of platelet physiology derives mostly from experiments using isolated platelets [15, 27, 28] . During hypotension or when platelets are affected by different storage conditions, platelet performance is seldom evaluated in vivo. Therefore, we used a new model to assess the hemostatic function of refrigerated platelets in vivo while recording multiple systemic parameters, and repetitive blood sampling for ex vivo evaluations.
Storage of platelets at RT, as dictated by current US blood-banking practice, allows platelets to survive up to 7 days [29] . The alternative cold storage, while reducing in vivo survival, preserves several in vitro hemostatic function measures and makes platelets less susceptible to bacterial contamination. Apheresis platelets that are cold stored, compared with RT, have more viable metabolic characteristics, perform better in functional tests, form stronger clots and release fewer inflammatory mediators [9] .
The in vivo hemostatic efficacy of platelets cold-stored for more than 72 h, in any form (WB, liquid plasma, platelet concentrates from WB or apheresis), has not been rigorously investigated. Previous clinical studies of coldstored platelets involved WB stored for up to 24 h [30] or 48 h, [11] or platelet concentrates stored for up to 24 h [31] or 72 h [10, 32] . We now show, for the first time, that refrigerated platelets stored for 24 h and 120 h (5 days) adhere to thrombi formed under physiologic blood flow in normotensive and hypotensive conditions.
Our in vitro findings agree with previous data that refrigerated platelets are responsive to agonist stimulation [9] . In vitro, these platelets maintain their responsiveness to physiologic inhibitors, NO and prostacyclin [27] . We now report, using bleeding and thrombosis models, that refrigerated platelets are capable of adhering to laserinduced thrombi.
Our data also corroborate clinical study findings using refrigerated platelets, including those in which cold-stored platelets reversed bleeding time prolongation due to aspirin and reduced bleeding in thrombocytopenia [10, 12, 33] . We provide the first experimental evidence that cold-stored platelets have similar behavior to RT-stored platelets at sites of vessel injury in normotensive rats and in a rodent model of hemorrhagic shock. Altogether, the available data suggest that platelets stored at 4°C may be as good as an RT-stored transfusion product to treat acute bleeding. In these situations, the priority is for immediate hemostasis rather than a goal of a circulating lifespan for platelets. Just as importantly, we found that cold-stored platelets did not form thrombi in uninjured vessels. Previous clinical studies have also demonstrated beneficial hemostatic effects of cold-stored platelets [10, 11, 33] .
Although similar results were obtained for the adhesion of platelets with various storage times and temperatures, Hemostasis measurements from HEM animals also showed CT shortening after hemorrhage, suggesting that coagulation factors were activated, supporting thrombin production and exposure of large amounts of tissue factor, and consonant with previous findings in hemorrhaged rats [34, 35] . Although hypercoagulation may turn into hypocoagulation in a short period of time, hypocoagulable and hypercoagulable states may coexist in HS [34] [35] [36] . Therefore, the predominant state in a particular vascular bed will depend on time as well as on local and systemic pathophysiologic conditions [37] . In the thrombosis model, platelet adhesion was slightly reduced (or unchanged) in HEM animals (compared with NOR animals). Reduced flow or WSR may not explain why platelet adhesion was less during hypotension in some cases: other responses such as low hematocrit may have contributed to these findings. Systemic hematocrit was reduced in HEM animals during thrombus formation measurements, leading to an estimated microvascular hematocrit < 50% of the systemic (based on the vessel diameter range) [38] . In patients, low hematocrit is associated with prolonged bleeding [39] and higher blood loss [40] . Hematocrit affects the ability of platelets to marginate and to adhere to a wall [41] [42] [43] . Reduced hematocrit also indicates hemodilution, which may affect hemostasis through components not directly measured in our study. The aim of this study was not to compare the in vivo evaluation of platelet adhesion with results obtained from any in vitro assay. Although the injection of fluorescentlylabeled platelets was necessary for better cell identification and for quantification of platelet adhesion in vivo, the amount of infused platelets was relatively small to significantly affect the overall coagulation performance of NOR animals. However, the injection of cold-stored platelets in hemorrhaged rats showed hemostatic efficacy by forming stronger clots and correcting CT (Table 1) . Platelet adhesion measured in vivo using two models of laser-induced thrombus formation. In the thrombosis model the vascular wall is preserved, whereas in the bleeding model thrombi are formed after vessel rupture. Adhesion is expressed by mean fluorescence difference (DF) of injected platelets that adhered to thrombi of normotensive (NOR) and hemorrhaged (HEM) animals receiving platelets stored at room temperature (RT), or refrigerated (4°C) platelets stored for 24 h or 5 days. Using both models, adhesion was similar between animals that received RT and 4°C platelets (A, B, C and D). In the thrombosis model, adhesion was lower for HEM animals, regardless of the platelets they received (E). In the bleeding model, adhesion was higher for HEM animals, regardless of the storage used for the injected platelets (F). In the thrombosis model, adhesion was similar between NOR and HEM animals that received refrigerated platelets stored for 5 days (G), but higher in HEM animals when the bleeding model was used (H). Data from 232 microvessels (average of 19 thrombi/group), expressed as mean AE SEM of Arbitrary Units (A.U.) of ΔF. [Color figure can be viewed at wileyonlinelibrary.com] result of enhanced fibrin polymerization [44] . Our results support that platelets stored at 4°C have at least equal hemostatic function to RT-stored platelets during hemorrhage, possibly as a result of the platelets 'priming' state caused by cold storage [9] .
Limitations and applications
This study was not blinded and has other limitations. Platelets were collected by phlebotomy techniques, which may not completely recapitulate the changes experienced by platelets during apheresis and storage over longer time periods. We used laser-specific models of thrombus formation that may not necessarily reflect what is currently seen in human injuries. However, our results agree with ample data available using similar methodology [13, 23] . Thrombosis reviews point out that rodents are desirable for primary evaluation of compounds [45] , especially regarding rats and HS [21, 26] . Considering the above, results from rat platelet studies may only cautiously be transferred to human transfusion medicine. Rat blood RT-stored for 5 days was not studied because it would present deterioration of major components (including platelets) and relatively small clinical significance. Only one species (rats) was used and because animals were not resuscitated, more studies will be necessary to determine whether cold-stored platelets will be indicated in conditions including fluid resuscitation. Recent positive results on additive solutions [46] , mitochondrial function [47] and vascular stability [48] suggest a promising future for refrigerated platelets. The complex vessel trauma scenario demanding platelet adhesion and thrombus formation [49] can only be surpassed by the overwhelming systemic changes during a simultaneous HS. Therefore, although the current model may be complex, offering limited information on mechanisms of platelet function and thrombus formation, it provides an excellent model for evaluating platelet function under real in vivo situations. If under these very difficult HS conditions cold-stored platelets adhered as well as native and RT-stored platelets, it is likely that refrigerated platelets have all the required machinery to perform their function.
Mice have been the most extensively used species in laser-based thrombosis studies [17, 18, 22] [50] . Although transgenic models and specific targeted molecules are available [51] , platelet adhesion studies typically do not monitor or alter systemic physiologic parameters such as blood pressure. Conversely, a wealth of knowledge exists on rat physiology/pathophysiology, particularly HS. Therefore, we combined a relevant HS rat model [19] [20] [21] 25] with wellknown laser-based methodologies [17, 18, 22, 23] .
Because systemic and local reactions occur during HS, the current in vivo model can be used when a combination of in vivo and in vitro testing must be performed, to complement in vitro coagulation studies, and to develop new hemostatic therapies. Considering the need for experimental models of trauma coagulopathy [52] , the ability to provide ROTEM results in addition to in vivo platelet adhesion and thrombus formation evaluations, together with microhemodynamics, blood biochemistry and other cardiorespiratory parameters, is a novelty of the method, giving added clinical significance to the model used in the current studies.
Conclusions
We evaluated thrombus formation and platelet adhesion after different storage conditions in animals under extensive systemic physiologic monitoring using a new in vivo model. Using confocal intravital videomicroscopy, we found that refrigerated platelets stored up to 5 days participated as well as RT-stored platelets in thrombi formed during HS, suggesting that refrigerated platelets are effective under hypotensive situations. Video S1. Venules in the exteriorized cremaster of monitored instrumented anesthetized rats during hemorrhagic hypotension imaged using bright-field and confocal intravital microscopy. Video S2. Cold-stored platelets in a thrombus imaged using halogen bright-field and confocal intravital microscopy. Video S3. Cold-stored platelets in a thrombus imaged in the exteriorized cremaster of a monitored instrumented anesthetized rat during hemorrhagic hypotension using bright-field and confocal intravital microscopy.
